Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention: a pragmatic randomised controlled trial in Pakistan

This first study to covertly assess deal-making between doctors and pharmaceutical company representatives demonstrated that the practice is strikingly widespread in the study setting and suggested that substantial reductions are unlikely to be achieved by educational interventions alone. Our novel method provides an opportunity to generate evidence on deal-making between doctors and pharmaceutical companies elsewhere.

Authors

Institutions

Publication Details

Journal
BMJ Global Health
Published
2024-12-01
DOI
https://doi.org/10.1136/bmjgh-2024-016055
Citations
2
Primary Topic
Pharmaceutical industry and healthcare
Type
article
Field-Weighted Citation Impact
0.93

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention: a pragmatic randomised controlled trial in Pakistan

Iqbal Azam, Charles Opondo, Muhammad Naveed Noor, Sadia Shakoor et al.
2 citations
BMJ Global Health
Pharmaceutical industry and healthcare
0.93
article

Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention: a pragmatic randomised controlled trial in Pakistan

Iqbal Azam, Charles Opondo, Muhammad Naveed Noor, Sadia Shakoor, Nina van der Mark, Wafa Aftab, Sabeen Sharif Khan, Zafar Mirza, Sameen Siddiqi, S A Kazmi, Afshan Khurshid Isani, Johanna Hanefeld, Allauddin Siddiqi, Afifah Rahman-Shepherd, Natasha Ali, Faisal Ziauddin, Virginia Wiseman, Mishal Khan, Robyna Irshad Khan, Faiza Bhutto, Rumina Hasan, Amna Rehana Siddiqui, Zainab Hasan
article en
2 citations

Abstract

This first study to covertly assess deal-making between doctors and pharmaceutical company representatives demonstrated that the practice is strikingly widespread in the study setting and suggested that substantial reductions are unlikely to be achieved by educational interventions alone. Our novel method provides an opportunity to generate evidence on deal-making between doctors and pharmaceutical companies elsewhere.

BMJ Global HealthVol. 9(12)
Aga Khan University (PK), Shifa Tameer-e-Millat University (PK), Government of Pakistan (PK), Jinnah Sindh Medical University (PK), Higher Education Commission (PK), UNSW Sydney (AU), University of Oxford (GB), London School of Hygiene & Tropical Medicine (GB), Faculty of Public Health (GB), University of Bergen (NO), University of Manitoba (CA), Ziauddin University (PK)
Medical Research Council
Openalex Percentile: Top 23%
Pharmaceutical industry and healthcare
0.93
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.